4//SEC Filing
Mandell James 4
Accession 0001209191-18-050625
CIK 0001293971other
Filed
Sep 11, 8:00 PM ET
Accepted
Sep 12, 4:07 PM ET
Size
9.0 KB
Accession
0001209191-18-050625
Insider Transaction Report
Form 4
Mandell James
Director
Transactions
- Sale
Common Stock
2018-09-10$152.00/sh−67$10,184→ 1,000 total - Sale
Common Stock
2018-09-10$150.06/sh−432$64,825→ 1,568 total - Sale
Common Stock
2018-09-10$151.22/sh−501$75,762→ 1,067 total
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on July 26, 2018.
- [F2]The range in prices for the transaction reported on this line was $150.00 to $150.125. The average weighted price was $150.0579. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]The range in prices for the transaction reported on this line was $151.10 to $151.70. The average weighted price was $151.2209. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F4]The range in prices for the transaction reported on this line was $152.00 to $152.05. The average weighted price was $152.0015. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Documents
Issuer
bluebird bio, Inc.
CIK 0001293971
Entity typeother
Related Parties
1- filerCIK 0001595896
Filing Metadata
- Form type
- 4
- Filed
- Sep 11, 8:00 PM ET
- Accepted
- Sep 12, 4:07 PM ET
- Size
- 9.0 KB